SM
IMGN

SG3 Management’s Immunogen Inc IMGN Stock Holding History

SG3 Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-25,000
Closed -$142K – 1353
2021
Q3 		$142K Buy
25,000
+16,500
+194% +$95.3K ﹤0.01% 823
2021
Q2 		$56K Buy
+8,500
New +$59.3K ﹤0.01% 937
2020
Q2 		– Sell
-10,000
Closed -$34K – 732
2020
Q1 		$34K Buy
+10,000
New +$43.7K ﹤0.01% 325

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

SG3 Management's IMGN Position: Q4 2021 in Review

SG3 Management sold out of Immunogen Inc (IMGN) in Q4 2021, closing a stake of 25,000 shares — an estimated $142K sold.

SG3 Management first reported a position in IMGN in Q1 2020 and held it in 3 quarters. The position peaked at $142K in Q3 2021. 236 funds tracked by Wall St. Rank hold IMGN as of Q4 2021.

  • SG3 Management reported no remaining Immunogen Inc position as of Q4 2021 after selling out during the quarter.
  • SG3 Management sold 25,000 Immunogen Inc shares in Q4 2021, an estimated $142K.
  • SG3 Management first reported a position in Immunogen Inc in Q1 2020 and held it in 3 quarters.
  • SG3 Management's Immunogen Inc position peaked at $142K in Q3 2021.
  • 236 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2021.

Based on SG3 Management's 13F filing for Q4 2021, filed 15 Feb 2022.